Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Biotechnology
Cambridge, UK-based Avacta Group today announced that AffyXell Therapeutics, the joint venture with South Korean drugmaker Daewoong Pharmaceutical, has closed a Series A venture capital investment of $7.3 million to further develop its pipeline of next generation cell and gene therapies. 1 February 2021
Pharmaceutical
Milan, Italy-based Enthera Pharmaceuticals today announced the final closing of its Series A financing, with a total financing of 35 million euros ($42.3 million). 28 January 2021
Generics
The European Investment Bank (EIB) will provide 20 million euros ($24.3 million) to finance the research, development and innovation program of Galenicum, a pharmaceutical company founded in Barcelona, Spain. 27 January 2021
Pharmaceutical
The Indian pharma space is teeming with positivity with brokerage companies anticipating a healthy quarter scorecard from the sector. As investors turn to pharma, India's role as an emerging bulk drug supplier has caught the fancy of many. 21 January 2021
Biotechnology
Investors will continue to chase after Chinese biotechs despite obvious bubbles, said speakers from several venture capitals and biotechs at China Biomed innovation and investment conference held online on January 12, reports The Pharma Letter’s correspondent Wang Fangqing. 18 January 2021
Pharmaceutical
Struggling biotech Acorda Therapeutics has announced plans to sell a manufacturing site for one of its key assets, as part of a restructuring plan aimed at keeping the ship afloat. 14 January 2021
Pharmaceutical
NewAmsterdam Pharma (NAP), a Dutch clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases, has completed an oversubscribed 160 million-euro ($196 million) Series A funding round. 14 January 2021
Biotechnology
The Novo Seeds portfolio company IO Biotech has raised 127 million euros ($155 million) in a Series B financing. 13 January 2021
Biotechnology
US biotech EQRx, which is committed to developing and delivering important new medicines at lower prices, today announced that it has raised $500 million in Series B financing. 11 January 2021
Biotechnology
US biotech DiCE Molecules, which is leveraging its proprietary DNA-encoded library platform to discover and develop next-generation therapeutics in immunology, has announced the completion of an $80 million Series C financing. 11 January 2021
Biotechnology
US biotech Affinivax, which is pioneering the development of a novel class of vaccines with its MAPS (Multiple Antigen Presenting System) platform, today said it has closed a $226 million Series C financing, co-led by new investors Rock Springs Capital and Foresite Capital. 8 January 2021
Biotechnology
Leaps by Bayer has led a $105 million Series B financing round in the gene circuit company, Senti Biosciences. 6 January 2021
Biotechnology
Eleva GmhH, a Germany-based manufacturer of biologics, has secured up to 60 million euros ($73.7 million) in funding from Zukunftsfonds Heilbronn (ZFHN). 6 January 2021
Biotechnology
As the COVID-19 pandemic raged around the globe last year, biopharma capital markets were robust in 2020, with a record $13.5 billion raised in 81 initial public offerings (IPOs) and $41.1 billion in 256 follow-on offerings (FOs), noted SVB Leerink analyst Geoffrey Porges. 4 January 2021
Biotechnology
company Regenxbio has entered into an agreement to sell a portion of the royalty rights due to the company from Novartis Gene Therapies (formerly AveXis) from the net sales of Zolgensma (onasemnogene abeparvovec-xioi) to entities managed by Healthcare Royalty Management (HCR) for a gross purchase price of $200 million. 23 December 2020
Biotechnology
GlaxoSmithKline today said it will co-lead a Series A investment in Adrestia Therapeutics, a UK-based biotechnology company using cutting edge molecular biology to develop precision medicines. 18 December 2020
Biotechnology
California-based Neuron23, an early-stage biotech focused on developing precision medicines for genetically defined neurological and immunological diseases, has announced its launch backed by a combined $113.5 million Series A and B financing. 16 December 2020
Biotechnology
News of a merger deal for Israel-headquartered pre-clinical biopharma firm Anchiano Therapeutics sent the firm’s shares up as much as 183% early yesterday, and still up 87% at $2.8 by close of trading. 16 December 2020
Biotechnology
Californian investment group Westlake Village BioPartners has launched two new funds totaling $500 million, with the goal of promoting promising firms with innovative technologies. 15 December 2020
Biotechnology
Beijing’s Sinovac Biotech has secured approximately $500 million in funding for further development, capacity expansion and manufacturing of its coronavirus vaccine. 8 December 2020
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze